Collaborations Pharmaceuticals Regulations Sourcing 
IBM Services
MAY 9, 2024
For starters, healthcare organizations constantly encounter vast (and ever-increasing) amounts of highly regulated personal data. Healthcare organizations must adhere to data privacy regulations like HIPAA and GDPR. Issues with compliance and audit conduct also arise due to these scattered data sources.
Everest Group
JUNE 16, 2023
Despite challenges and regulations, the life sciences industry is actively exploring GAI’s possibilities. Although GAI can potentially disrupt the life sciences technology ecosystem in many significant ways, navigating the various risks and challenges that come with its implementation in this highly regulated industry will be critical.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Perficient Digital Transformation
OCTOBER 18, 2021
The results of these analyses help pharmaceutical companies better understand the impact drugs can have on the human body and influences critical decisions in the drug manufacturing process. Non-compartmental analysis (NCA) is an essential activity within the drug development process.
Transperfect
SEPTEMBER 16, 2021
The TMF is a source of evidence examined by regulators to ensure credible clinical trial data and protection of patients’ rights and safety. Their scalability allows them to work globally with small biotechnology or large pharmaceutical companies, depending on an organization’s needs. Why You Need Them.
Globalization Partners
NOVEMBER 8, 2021
The TCA seeks to keep the terms fair for both parties, so both the UK and EU had to agree on shared social, environmental, and employment standards and regulations. Food and agriculture: A large portion of the food in UK grocery stores is sourced from the EU.
Globalization Partners
APRIL 8, 2022
Machinery, vehicles, chemicals, and other manufactured goods are the most significant source of exports and imports between the regions. The two countries are already part of a Fintech Bridge Alliance , which ensures shared regulations and connections to key industry stakeholders. Emerging biomedical technology and pharmaceuticals.
IBM Services
FEBRUARY 16, 2023
Globally, the shifting policy debate around access and affordability of patented pharmaceuticals exerts additional pressures. The cost of active pharmaceutical ingredients has increased by up to 70% since 2018. Manufacturing costs and costs of clinical trials will continue to rise.
Expert insights. Personalized for you.
72 
Let's personalize your content